Difficulty: Medium
Average Score: 84%
Practice
Clofibrate (Atromid-S) is the drug of choice for treatment of broad-beta hyperlipidemia (type III). This consideration is:
Correct answer
A
Rationale
The correct answer is A: TRUE. Clofibrate is the drug of choice for type III hyperlipidemia due to its ability to reduce triglyceride levels. Other choices (B, C, D) are incorrect because they do not accurately reflect the specific drug recommended for type III hyperlipidemia. Choice B is incorrect as clofibrate is indeed the preferred drug for this condition. Choice C is incorrect as not all options are valid in this context. Choice D is incorrect as there is a specific drug recommended for type III hyperlipidemia.